1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. デバイスタイプ別スニペット
3.2. エンドユーザー別スニペット
3.3. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 技術の進歩
4.1.2. 阻害要因
4.1.2.1. 手続きの複雑さ
4.1.2.2. 治療と機器に伴う高コスト
4.1.2.3. 熟練した専門家の不足
4.1.2.4. 厳しい規制要件
4.1.3. ビジネスチャンス
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
5.5. アンメット・ニーズ
5.6. PESTEL分析
5.7. 特許分析
5.8. SWOT分析
6. デバイスタイプ別
6.1. はじめに
6.1.1. デバイスタイプ別市場規模分析および前年比成長率分析(%)
6.1.2. 市場魅力度指数（デバイスタイプ別
6.2. 交差型CTO装置
6.2.1. はじめに
6.2.2. 市場規模分析と前年比成長率分析(%)
6.3. トゥルーパス
6.4. バイアンスデバイス
6.5. リエントリー装置
6.6. センタークロスCTO装置
6.7. プロディジー
6.8. クロスロック
6.9. その他
7. エンドユーザー別
7.1. はじめに
7.1.1. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
7.1.2. 市場魅力度指数、エンドユーザー別
7.2. 病院・クリニック*市場
7.2.1. はじめに
7.2.2. 市場規模分析と前年比成長率分析(%)
7.3. 外来手術センター
7.4. その他
8. 地域別
8.1. はじめに
8.1.1. 地域別市場規模分析および前年比成長率分析(%)
8.1.2. 市場魅力度指数、地域別
8.2. 北米
8.2.1. 序論
8.2.2. 主な地域別ダイナミクス
8.2.3. 市場規模分析および前年比成長率分析(%)、デバイスタイプ別
8.2.4. 市場規模分析および前年比成長率分析（%）：エンドユーザー別
8.2.5. 市場規模分析および前年比成長率分析(%)、国別
8.2.5.1. 米国
8.2.5.2. カナダ
8.2.5.3. メキシコ
8.3. ヨーロッパ
8.3.1. はじめに
8.3.2. 主な地域別動向
8.3.3. 市場規模分析および前年比成長率分析(%)、デバイスタイプ別
8.3.4. 市場規模分析および前年比成長率分析 (%)、エンドユーザー別
8.3.5. 市場規模分析および前年比成長率分析(%)、国別
8.3.5.1. ドイツ
8.3.5.2. イギリス
8.3.5.3. フランス
8.3.5.4. イタリア
8.3.5.5. スペイン
8.3.5.6. その他のヨーロッパ
8.4. 南米
8.4.1. はじめに
8.4.2. 地域別主要市場
8.4.3. 市場規模分析および前年比成長率分析（%）（デバイスタイプ別
8.4.4. 市場規模分析および前年比成長率分析（%）：エンドユーザー別
8.4.5. 市場規模分析および前年比成長率分析(%)、国別
8.4.5.1. ブラジル
8.4.5.2. アルゼンチン
8.4.5.3. その他の南米諸国
8.5. アジア太平洋
8.5.1. はじめに
8.5.2. 主な地域別ダイナミクス
8.5.3. 市場規模分析および前年比成長率分析（%）（デバイスタイプ別
8.5.4. 市場規模分析および前年比成長率分析（%）：エンドユーザー別
8.5.5. 市場規模分析および前年比成長率分析(%)、国別
8.5.5.1. 中国
8.5.5.2. インド
8.5.5.3. 日本
8.5.5.4. 韓国
8.5.5.5. その他のアジア太平洋地域
8.6. 中東・アフリカ
8.6.1. 序論
8.6.2. 主な地域別ダイナミクス
8.6.3. 市場規模分析および前年比成長率分析（%）（デバイスタイプ別
8.6.4. 市場規模分析およびYoY成長率分析（%）、エンドユーザー別
9. 競合情勢
9.1. 競争シナリオ
9.2. 市場ポジショニング／シェア分析
9.3. M&A分析
10. 企業プロフィール
10.1. Medtronic *
10.1.1. 会社概要
10.1.2. 製品ポートフォリオと内容
10.1.3. 財務概要
10.1.4. 主な展開
10.2. Boston Scientific Corporation
10.3. Avinger Inc.
10.4. Cardinal Health
10.5. Koninklijke Philips N.V
10.6. Cook Medical Incorporated
10.7. Becton, Dickinson and Company
10.8. Baylis Medical Company
10.9. Soundbite Medical Solution
10.10. Terumo Corporation（※リストはありません。）
11. 付録
11.1. 会社概要とサービス
11.2. お問い合わせ
The global peripheral CTO market reached US$ 12.02 billion in 2023 and is expected to reach US$ 18.05 million by 2031, growing at a CAGR of 5.3% during the forecast period 2024-2031.
A peripheral chronic total occlusion (CTO) is a blockage in a peripheral artery that is caused by a buildup of plaque over time. CTOs are a type of peripheral artery disease (PAD) and can be challenging to treat with endovascular techniques. Chronic total occlusions (CTO) are important anatomic variants for interventional cardiologists. Peripheral arteries, which supply blood through the legs along with other arteries outside the heart, are affected by this disorder. This reduced blood flow can cause pain, ulcers that remain unhealed, and in severe instances, even limb loss.
Specialized medical instruments called peripheral CTO devices are intended to treat chronic complete occlusions of peripheral arteries. Assisting to travel through or around the occlusion and restoring blood flow are devices such as atherectomy systems, crossing catheters, guidewires, and re-entry devices. These gadgets' technological improvements have increased success rates by providing more precision, flexibility, and support during difficult procedures.
Market Dynamics: Drivers
Increasing technological advancements
The increasing technological advancements propel the market growth. For instance, in April 2024, Simpsons Interventions, a California-based healthcare technology company, received the FDA’s breakthrough device designation for its Acolyte Image Guided Crossing and Re-Entry Catheter System. The new device is designed to help interventional cardiologists treat patients with coronary chronic total occlusions (CTOs) who do not respond to medical therapy. It delivers real-time optical coherence tomography (OCT) visualization that helps with the guidance and placement of guidewires during revascularization procedures.
CTOs occur when patients develop 100% stenosis in a coronary artery. Crossing the CTO can provide certain challenges for interventional specialists—any complications may require the care team to shift to coronary artery bypass graft surgery (CABG). According to Simpsons Interventions, their device’s real-time OCT capabilities improve cardiologist performance and reduce the risk of patients requiring CABG. There are many technological advancements in recent times that act as a driving factor for the peripheral CTO market.
Restraints
Factors such as the complexity of procedures, high costs associated with the treatment and devices, shortage of skilled professionals, and stringent regulatory requirements for the approval of new treatments are expected to hamper the market.
Segment Analysis
The peripheral CTO market is segmented based on device type, end-user, and region.
The segment crossing CTO device accounted for approximately 48.3% of the peripheral CTO market share
The crossing CTO device segment is expected to hold the largest market share over the forecast period. In this segment, the technological advancements and rising funds for private manufacturers for device development would drive this market. A crossing CTO device is a tool used to navigate through a chronic total occlusion (CTO) to deliver guidewires and treat peripheral arterial disease (PAD).
For instance, in May 2023, Bentley, a global leader in the endovascular treatment for aortic and peripheral vascular disease, announced their first product launch in the United States with the BeBack crossing catheter designed for the treatment of heavily calcified lesions. The BeBack catheter is designed for steering through Chronic Total Occlusions (CTO), which often is the most challenging part when treating heavily calcified lesions. The catheter is available in an 80 and 120-cm catheter in both a 2.9F and 4F size. The device makes use of a steerable and in-length adjustable Nitinol needle, which is used for crossing and targeted re-entry purposes.
Geographical Analysis
North America accounted for approximately 42.6% of the peripheral CTO market share
North America region is expected to hold the largest market share over the forecast period. The technological advancements, and growing awareness among people, in this region, help to propel the market.
For instance, in March 2024, Becton Dickinson and Company started a clinical trial of its investigational vascular-covered stent in people with peripheral arterial disease (PAD). The study is enrolling 315 patients to evaluate the safety and effectiveness of the self-expanding nitinol implant with a fluoropolymer coating. Becton Dickinson and Company's single-arm clinical trial recently enrolled its first patient at a site in Iowa. The site is one of up to 40 that BD plans to activate across the U.S., Europe, Australia, and New Zealand as it works to enroll PAD patients and track them for 36 months.
Moreover, in April 2024, Abbott received FDA approval for its latest drug-eluting scaffold, designed to help reopen arteries in the legs that have become clogged below the knee. The Esprit BTK System aims to treat the most severe form of peripheral artery disease, a condition known as chronic limb-threatening ischemia, or CLTI, where hampered blood flow can lead to foot or lower leg amputations.
Market Segmentation
By Device Type
Crossing CTO Device
Truepath
Viance Device
Re-Entry Device
Centercross CTO Device
Prodigy
Crosslock
Others
By End-User
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Middle East and Africa
Competitive Landscape
The major global players in the peripheral CTO market include Medtronic, Boston Scientific Corporation, Avinger Inc., Cardinal Health, Koninklijke Philips N.V, Cook Medical Incorporated, Becton, Dickinson and Company, Baylis Medical Company, Soundbite Medical Solution, Terumo Corporation among others.
Key Developments
In August 2024, Avinger, Inc. announced the full commercial launch of the Pantheris LV image-guided directional atherectomy system. Avinger's proprietary technology incorporates an onboard image-guidance system to allow physicians to see inside the artery during an atherectomy or CTO-crossing procedure by using an imaging modality called optical coherence tomography, or OCT. During the procedure, high-resolution intravascular OCT images are displayed on Avinger's Lightbox console in real time to guide therapy.
In June 2024, Royal Philips announced the first implant of the Duo Venous Stent System, an implantable medical device indicated to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI), following premarket approval (PMA) from the U.S. Food and Drug Association (FDA).
Why Purchase the Report?
To visualize the peripheral CTO
Market Segmentation based on device type, end-user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of peripheral CTO market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in Excel consisting of key products of all the major players.
The peripheral CTO market report would provide approximately 51 tables, 54 figures, and 181 Pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Device Type
3.2. Snippet by End-User
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Technological Advancements
4.1.2. Restraints
4.1.2.1. Complexity of Procedures
4.1.2.2. High Costs Associated with the Treatment and Devices
4.1.2.3. Shortage of Skilled Professionals
4.1.2.4. Stringent Regulatory Requirements
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
6. By Device Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
6.1.2. Market Attractiveness Index, By Device Type
6.2. Crossing CTO Device *
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Truepath
6.4. Viance Device
6.5. Re-Entry Device
6.6. Centercross CTO Device
6.7. Prodigy
6.8. Crosslock
6.9. Others
7. By End-User
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.1.2. Market Attractiveness Index, By End-User
7.2. Hospitals and Clinics*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Ambulatory Surgical Centers
7.4. Others
8. By Region
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.5.1. The U.S.
8.2.5.2. Canada
8.2.5.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.5.1. Germany
8.3.5.2. UK
8.3.5.3. France
8.3.5.4. Italy
8.3.5.5. Spain
8.3.5.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.5.1. Brazil
8.4.5.2. Argentina
8.4.5.3. Rest of South America
8.5. Asia-Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.5.1. China
8.5.5.2. India
8.5.5.3. Japan
8.5.5.4. South Korea
8.5.5.5. Rest of Asia-Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9. Competitive Landscape
9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis
10. Company Profiles
10.1. Medtronic *
10.1.1. Company Overview
10.1.2. Product Portfolio and Description
10.1.3. Financial Overview
10.1.4. Key Developments
10.2. Boston Scientific Corporation
10.3. Avinger Inc.
10.4. Cardinal Health
10.5. Koninklijke Philips N.V
10.6. Cook Medical Incorporated
10.7. Becton, Dickinson and Company
10.8. Baylis Medical Company
10.9. Soundbite Medical Solution
10.10. Terumo Corporation (*LIST NOT EXHAUSTIVE)
11. Appendix
11.1. About Us and Services
11.2. Contact Us
❖ 世界の末梢CTO市場に関するよくある質問(FAQ) ❖
・末梢CTOの世界市場規模は？
→DataM Intelligence社は2023年の末梢CTOの世界市場規模を120億2,000万米ドルと推定しています。
・末梢CTOの世界市場予測は？
→DataM Intelligence社は2031年の末梢CTOの世界市場規模を180億5,000万米ドルと予測しています。
・末梢CTO市場の成長率は？
→DataM Intelligence社は末梢CTOの世界市場が2024年～2031年に年平均5.3%成長すると予測しています。
・世界の末梢CTO市場における主要企業は？
→DataM Intelligence社は「Medtronic、Boston Scientific Corporation、Avinger Inc.、Cardinal Health、Koninklijke Philips N.V.、Cook Medical Incorporated、Becton, Dickinson and Company、Baylis Medical Company、Soundbite Medical Solution、Terumo Corporationなど ...」をグローバル末梢CTO市場の主要企業として認識しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、納品レポートの情報と少し異なる場合があります。
